Archive Newsletter

1. 04.30.26 -- Validating Candel's BLA-Ready Analytics Profile 4/30/2026
   04/30/26 Cell & Gene Newsletter
2. 04.29.26 -- Master pipetting, PCR, and NGS for cell and gene workflows. 4/29/2026

   04/29/26 Cell & Gene Newsletter

3. 04.29.26 -- Reprogramming T-Cell Access To Solid Tumors Via Improved Trafficking And Entry 4/29/2026
   04/29/26 Cell & Gene Newsletter
4. 04.28.26 -- What FDA CRLs Reveal, USP <665> Countdown, Biowaiver Webinar 4/28/2026

   04/28/26 Cell & Gene Newsletter

5. 04.28.26 -- Target Selection Drives The Future Of CAR-T Therapy In Solid Tumors 4/28/2026
   04/28/26
6. 04.28.26 -- STREAM Edition: Advancing Early Detection In Rare Cancers with Catriona Jamieson, M.D., Ph.D. 4/28/2026

   04/28/26 Cell & Gene Newsletter

7. 04.27.26 -- March 2026 — CDMO Opportunities And Threats Report 4/27/2026
   04/27/26 Cell & Gene Newsletter
8. 04.25.26 -- Why A Cell Therapy CEO Waited Until Phase III To Outsource 4/25/2026
   04/25/26
9. 04.24.26 -- U.S. Pharma Tariffs And MFN Become Law After April 2 Update 4/24/2026
   04/24/26 Cell & Gene Newsletter
10. 04.23.26 -- Mastering Biotech's Insourcing/Outsourcing Trade-Offs 4/23/2026
    04/23/26 Cell & Gene Newsletter